These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22197450)

  • 1. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer treatment and thrombosis.
    Falanga A; Marchetti M
    Thromb Res; 2012 Mar; 129(3):353-9. PubMed ID: 22119391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis and hemostatic abnormalities in hematological malignancies.
    Colombo R; Gallipoli P; Castelli R
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):441-50. PubMed ID: 25018062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
    Zamagni E; Brioli A; Tacchetti P; Zannetti B; Pantani L; Cavo M
    Semin Thromb Hemost; 2011 Apr; 37(3):209-19. PubMed ID: 21455855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects on hemostatic function of drugs used in hematologic malignancies.
    Zakarija A; Kwaan HC
    Semin Thromb Hemost; 2007 Jun; 33(4):355-64. PubMed ID: 17525893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis in multiple myeloma.
    Zangari M; Elice F; Fink L; Tricot G
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
    Palumbo A; Rajkumar SV; Dimopoulos MA; Richardson PG; San Miguel J; Barlogie B; Harousseau J; Zonder JA; Cavo M; Zangari M; Attal M; Belch A; Knop S; Joshua D; Sezer O; Ludwig H; Vesole D; Bladé J; Kyle R; Westin J; Weber D; Bringhen S; Niesvizky R; Waage A; von Lilienfeld-Toal M; Lonial S; Morgan GJ; Orlowski RZ; Shimizu K; Anderson KC; Boccadoro M; Durie BG; Sonneveld P; Hussein MA;
    Leukemia; 2008 Feb; 22(2):414-23. PubMed ID: 18094721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
    Falanga A; Rickles FR
    Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-related thrombosis in hematologic malignancies.
    Nadir Y; Hoffman R; Brenner B
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
    Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
    Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis in children with hematologic malignancies.
    Schobess R; Kempf-Bielack B; Schwabe D; Sträter R; Nowak-Göttl U
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E2. PubMed ID: 16029968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of thromboembolism in hematologic malignancies.
    Chong BH; Lee SH
    Semin Thromb Hemost; 2007 Jun; 33(4):435-48. PubMed ID: 17525901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.
    Uaprasert N; Voorhees PM; Mackman N; Key NS
    Eur J Cancer; 2010 Jul; 46(10):1790-9. PubMed ID: 20385482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in the hematologic malignancies.
    Falanga A; Marchetti M
    J Clin Oncol; 2009 Oct; 27(29):4848-57. PubMed ID: 19752334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of thrombosis in patients with hematologic malignancies.
    Piccioli A; Vianello F; Prandoni P
    Curr Hematol Rep; 2002 Sep; 1(1):79-83. PubMed ID: 12901128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in the hematologic malignancies.
    Falanga A; Marchetti M; Russo L
    Curr Opin Oncol; 2012 Nov; 24(6):702-10. PubMed ID: 23014188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism incidence in hematologic malignancies.
    Kekre N; Connors JM
    Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates.
    Gieseler F
    Thromb Haemost; 2008 Jun; 99(6):1001-7. PubMed ID: 18521500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period.
    Hall R; Mazer CD
    Anesth Analg; 2011 Feb; 112(2):292-318. PubMed ID: 21212258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.